Theravance Biopharma Inc (TBPH) — Cash Flow Reinvestment Rate
Theravance Biopharma Inc (TBPH) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting $36.29 Million (capex $34.00K plus investments $-36.26 Million) from operating cash flow of $208.07 Million. Check how high is Theravance Biopharma Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Theravance Biopharma Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Theravance Biopharma Inc across 1 annual periods. Explore TBPH long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Theravance Biopharma Inc (2025–2025)
Year-by-year capital reinvestment analysis for Theravance Biopharma Inc. For live market cap and broader valuation context, see TBPH market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | $105.28 Million | $238.54 Million | $42.00K | — |